Today’s aircraft missions demand more from portable mission displays. Crews need access to critical information, mission applications and aircraft data in increasingly connected, time-sensitive operational environments. While portable mission displays provide mobility and situational awareness, general-purpose and ruggedized IT devices were not designed to operate as part of an airborne tactical mission environment. The challenge […]
The Food & Beverage manufacturing sector operates under relentless pressure: razor-thin margins, high heat and cooling demands, volatile energy markets and aggressive corporate net-zero targets. Ensuring 24/7 operational uptime while driving down energy intensity requires a radical rethink of traditional utility infrastructure. Join energy expert and business development manager Mirko Markovic from E.ON Energy Infrastructure […]
As part of the strategic evolution of our clinical data portfolio, Clinical Data Management Innovation (CDMI) and Clinical Trials in Rare Diseases (CTRD) are now part of a unified event: NextGen Clinical Data 2027. As the flagship event in our new NextGen series, this gathering will bring together clinical data, analytics, and operations leaders to […]
For sponsors and CROs running clinical trials, agentic AI might be as scary as it is compelling. There’s no end to its potential to create efficiencies and improvements in i That’s changing quickly as two viable paths emerge for responsible AI in clinical trials: vendor-driven AI in a closed system, or user-led AI in an […]
Why attend? 为何参会？ Navigate Local Challenges: Gain critical insights into the unique complexities of clinical trial supply chains in China, including import/export regulations, regional distribution, and local manufacturing. 破解本土化难题深度解析中国临床试验供应链特有的复杂挑战，包括进出口监管政策、区域配送网络布局及本土化生产策略等核心议题。 Regulatory Expertise: Stay updated on China’s regulatory environment, ensuring compliance while minimizing delays and risks in your clinical trial supply processes. 掌握监管先机实时获取中国药监动态，系统学习如何在确保合规前提下，规避供应链延误风险与质量隐患。 Build Strategic Partnerships: Connect […]
Why attend? 为何参会？ Access Local Expertise: Gain insights into the unique challenges and opportunities within China’s clinical trials landscape, directly from local and international experts. 获取本土洞见直击中国临床试验生态的独特挑战与机遇，聆听中外专家的第一手经验分享。 Regulatory Updates: Stay ahead with the latest regulatory developments and compliance strategies essential for navigating China’s evolving healthcare environment. 掌握法规动态获取中国快速演变的医疗监管政策最新进展，学习合规策略以规避风险。 Industry Networking: Build meaningful connections with leading CROs, […]
The share of registered federal lobbyists working on AI issues has more than doubled since 2023, both leading AI labs opened Washington offices within the past year, and the agencies buying AI are, by their own accounting, short on the compute and people to deploy it. For AI companies, the question is no longer whether […]
Modernizing a legacy plant doesn’t have to mean ripping and replacing the systems that already work. But connecting existing equipment, introducing new technologies, and scaling digitalization across a brownfield environment can be complex. So how are industrial leaders doing it successfully? Join industry experts as they unpack real-world modernization initiatives in complex industrial environments—including what […]
Real-world evidence needs are becoming more precise, especially as life sciences teams look to support lifecycle evidence generation, potential label expansion, regulatory-aligned evidence packages, and stronger value stories. Our previous webinar discussed how MarketScan provides a trusted claims foundation with longitudinal patient journeys, healthcare utilization, treatment patterns, and actual cost measurement across large U.S. populations. […]
Obesity clinical development has entered a paradoxical phase. Demand for trial participation has never been higher, yet obesity studies continue to experience some of the steepest attrition rates in clinical research. At the same time, the obesity treatment landscape is becoming increasingly differentiated, with sponsors competing not only on efficacy, but also on tolerability, persistence, […]